Immuron Limited Banner Image

Immuron Limited

  • Ticker IMRN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Immuron Limited Logo Image
  • 11-50 Employees
  • Based in Melbourne, Australia
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle.
4.8 / 5.0 (94)

Immuron Limited reports have an aggregate usefulness score of 4.8 based on 94 reviews.

Immuron Limited

Most Recent Annual Report

Immuron Limited
MOST RECENT 2020 Annual Report

Older/Archived Annual Reports

Immuron Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!